Raxone (idebenone) recommended for use within NHS Wales for the treatment of visual impairment in adolescent and adult patients with Leber’s Hereditary Optic Neuropathy (LHON) FirstWord Pharma, 22 Apr 2021 Tags: Press Release Raxone Chiesi NHS Wales Marketing